Extraction Technologies for Medicinal and Aromatic ... - Capacity4Dev
Extraction Technologies for Medicinal and Aromatic ... - Capacity4Dev
Extraction Technologies for Medicinal and Aromatic ... - Capacity4Dev
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
EXTRACTION TECHNOLOGIES FOR MEDICINAL AND AROMATIC PLANTS<br />
14 Quality Control of <strong>Medicinal</strong><br />
<strong>and</strong> <strong>Aromatic</strong> Plants <strong>and</strong><br />
their Extracted Products by<br />
HPLC <strong>and</strong> High Per<strong>for</strong>mance<br />
Thin Layer Chromatography<br />
Abstract<br />
K. Vasisht<br />
The interest in medicinal plants <strong>and</strong> their products has increased manifold in recent<br />
years. The increasing public dem<strong>and</strong> <strong>for</strong> natural medicines has resulted in increased<br />
commercial activity <strong>and</strong> production of these medicines. There is also increasing concern<br />
<strong>for</strong> ensuring quality <strong>and</strong> safety of plant medicines. Plant drugs, unlike active pharmaceutical<br />
ingredients, possess some inherent limitations which deter the process<br />
of laying st<strong>and</strong>ards <strong>for</strong> these drugs. This aspect has received considerable attention<br />
from different quarters including policy planners, scientists <strong>and</strong> manufacturers. This<br />
paper describes briefl y the roles of high per<strong>for</strong>mance thin layer chromatography <strong>and</strong><br />
high per<strong>for</strong>mance liquid chromatography in quality assurance of plant products. Some<br />
practical aspects of these techniques are also discussed.<br />
14.1 Introduction<br />
The use of medicinal plants products has increased several<br />
fold during the last decades. Individual countries are also giving increasing<br />
emphasis to promote their use under the direction of the World Health Organization<br />
(WHO). Besides this, one fi nds enormous interest in natural products<br />
from the public, which is attributable to several factors. These medicines<br />
are af<strong>for</strong>dable, safer <strong>and</strong> better tolerated by the biological system.<br />
This has led to an increased consumption <strong>and</strong> cross-country movement of<br />
raw materials of medicinal plants.<br />
In some parts of the world, e.g. several places in Africa <strong>and</strong> Asia,<br />
traditional medicines are the only af<strong>for</strong>dable option. On the other h<strong>and</strong>, the<br />
same medicines are the option of choice in developed nations like Japan <strong>and</strong><br />
the United States <strong>and</strong> in the European States. Despite being the more common<br />
medical option in Africa, use of traditional medicines has not matured to<br />
the expected level. But, some countries in Asia, especially India <strong>and</strong> China,<br />
have developed them to a level that has benefited all countries of the world.<br />
Europe did not inherit a well-developed traditional system of<br />
medicine but it has put in place the strongest evidence-based <strong>and</strong> scientifically<br />
supported system of plant medicines. North America is the most prolific<br />
<strong>and</strong> flamboyant market <strong>for</strong> plant products, but government regulations are such<br />
that except <strong>for</strong> select plant drugs most are used as dietary supplements or<br />
239